{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T06:28:33Z","timestamp":1757312913088,"version":"3.41.2"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Digit. Health"],"abstract":"Background<\/jats:title>Neonatal jaundice affects more than half of neonates. As bilirubin values usually peak few days after hospital discharge, jaundice remains a leading cause of rehospitalization. The recently developed BiliPredics algorithm, integrated in the first CE-approved bilirubin prediction tool, predicts individual bilirubin progression for up to 60\u2005h into the future. Goal of the prospective study was to assess accuracy of this algorithm in predicting individual bilirubin prior to hospital discharge in neonates.<\/jats:p><\/jats:sec>Methods<\/jats:title>A prospective multi-center study was conducted in 2021 at the University Children's Hospitals in T\u00fcbingen and Regensburg, Germany. Various scenarios differing in type and number of bilirubin measurements and in prediction horizon were tested. Primary objective was prediction accuracy of the BiliPredics algorithm based on total serum bilirubin (TSB) measurements or based on transcutaneous bilirubin (TcB) measurements alone. Secondary objective was prediction accuracy based on combinations of TSB and TcB measurements. For assessment of accuracy, two validation metrics, absolute prediction error (<\/mml:mo>a<\/mml:mi>P<\/mml:mi>E<\/mml:mi><\/mml:mrow>)<\/mml:mo><\/mml:math><\/jats:inline-formula> and relative prediction error (<\/mml:mo>r<\/mml:mi>P<\/mml:mi>E<\/mml:mi><\/mml:mrow>)<\/mml:mo><\/mml:math><\/jats:inline-formula>, and two clinical acceptance conditions, margin of error of the 95%-confidence interval (95%-CI) and percentage of clinically relevant mis-predictions defined as a<\/mml:mi>P<\/mml:mi>E<\/mml:mi>><\/mml:mo>85<\/mml:mn>\u03bc<\/mml:mi>mol<\/mml:mi>\/<\/mml:mo>L<\/mml:mi><\/mml:mrow><\/mml:math><\/jats:inline-formula>, were investigated.<\/jats:p><\/jats:sec>Results<\/jats:title>Out of 455 enrolled neonates, 276 neonates met bilirubin inclusion criteria and were included in the analyses. Irrespective from tested prediction horizons, median r<\/mml:mi>P<\/mml:mi>E<\/mml:mi><\/mml:math><\/jats:inline-formula> was small (8.5% to 9.5%) utilizing TSB measurements for up to 30 and 60\u2005h and slightly higher (13.8%) utilizing TcB measurements for up to 48\u2005h. The same applied for median a<\/mml:mi>P<\/mml:mi>E<\/mml:mi><\/mml:math><\/jats:inline-formula>. Both clinical acceptance conditions were fulfilled across tested scenarios. Results for combined TSB-TcB scenarios up to a prediction horizon of 48\u2005h without adjustment for type of measurement were comparable to TSB and TcB scenarios fulfilling both clinical acceptance conditions.<\/jats:p><\/jats:sec>Conclusion<\/jats:title>Results from this prospective study in neonates confirm that the BiliPredics algorithm accurately predicts bilirubin progression up to 60\u2005h with TSB measurements and up to 48\u2005h with TcB or combined TSB-TcB measurements. As such, prediction tools utilizing this algorithm are expected to facilitate and safely optimize jaundice risk assessment at hospital discharge with the potential to reduce jaundice-related rehospitalizations.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fdgth.2025.1497165","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T16:01:54Z","timestamp":1739894514000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Assessing accuracy of BiliPredics algorithm in predicting individual bilirubin progression in neonates\u2014results from a prospective multi-center study"],"prefix":"10.3389","volume":"7","author":[{"given":"Britta","family":"Steffens","sequence":"first","affiliation":[]},{"given":"Gilbert","family":"Koch","sequence":"additional","affiliation":[]},{"given":"Corinna","family":"Engel","sequence":"additional","affiliation":[]},{"given":"Axel R.","family":"Franz","sequence":"additional","affiliation":[]},{"given":"Marc","family":"Pfister","sequence":"additional","affiliation":[]},{"given":"Sven","family":"Wellmann","sequence":"additional","affiliation":[]}],"member":"1965","published-online":{"date-parts":[[2025,2,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1056\/NEJM200102223440807","article-title":"Neonatal hyperbilirubinemia","volume":"344","author":"Dennery","year":"2001","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1056\/NEJMra1308124","article-title":"Bilirubin-induced neurologic damage\u2014mechanisms and management approaches","volume":"369","author":"Watchko","year":"2013","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3233\/NPM-210781","article-title":"Treatment practices and implementation of guidelines for hyperbilirubinemia and rebound hyperbilirubinemia","volume":"15","author":"So","year":"2022","journal-title":"J Neonatal Perinatal Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1177\/0009922814536924","article-title":"Rehospitalization during the first year of life by insurance status","volume":"53","author":"Schiltz","year":"2014","journal-title":"Clin Pediatr"},{"key":"B5","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1001\/jamapediatrics.2023.0059","article-title":"Diagnostic accuracy of portable, handheld point-of-care tests vs laboratory-based bilirubin quantification in neonates: a systematic review and meta-analysis","volume":"177","author":"Westenberg","year":"2023","journal-title":"JAMA Pediatr"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012660.pub2","article-title":"Transcutaneous bilirubinometry versus total serum bilirubin measurement for newborns","volume":"5","author":"Okwundu","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e0197888","DOI":"10.1371\/journal.pone.0197888","article-title":"Umbilical cord blood bilirubins, gestational age, and maternal race predict neonatal hyperbilirubinemia","volume":"13","author":"Castillo","year":"2018","journal-title":"PLoS One"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e896","DOI":"10.1542\/peds.2014-4058","article-title":"A model for predicting significant hyperbilirubinemia in neonates from China","volume":"136","author":"Han","year":"2015","journal-title":"Pediatrics"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e2022058859","DOI":"10.1542\/peds.2022-058859","article-title":"Clinical practice guideline revision: management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation","volume":"150","author":"Kemper","year":"2022","journal-title":"Pediatrics"},{"key":"B10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1542\/hpeds.2012-0103","article-title":"A quality project to improve compliance with AAP guidelines for inpatient management of neonatal hyperbilirubinemia","volume":"3","author":"Tartaglia","year":"2013","journal-title":"Hosp Pediatr"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e0196076","DOI":"10.1371\/journal.pone.0196076","article-title":"Adherence to hyperbilirubinemia guidelines by midwives, general practitioners, and pediatricians in Indonesia","volume":"13","author":"Sampurna","year":"2018","journal-title":"PLoS One"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e190858","DOI":"10.1001\/jamanetworkopen.2019.0858","article-title":"Rates of extreme neonatal hyperbilirubinemia and kernicterus in children and adherence to national guidelines for screening, diagnosis, and treatment in Sweden","volume":"2","author":"Alk\u00e9n","year":"2019","journal-title":"JAMA network Open"},{"key":"B13","doi-asserted-by":"publisher","first-page":"842548","DOI":"10.3389\/fphar.2022.842548","article-title":"Leveraging predictive pharmacometrics-based algorithms to enhance perinatal care-application to neonatal jaundice","volume":"13","author":"Koch","year":"2022","journal-title":"Front Pharmacol"},{"volume-title":"Pharmacokinetic-Pharmacodynamic Modeling and Simulation","year":"2006","author":"Bonate","key":"B14"},{"key":"B15","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/978-3-319-03080-7_7","article-title":"Mathematical concepts in pharmacokinetics and pharmacodynamics with application to tumor growth","volume-title":"Nonautonomous Dynamical Systems in the Life Sciences Lecture Notes in Mathematics","author":"Koch","year":"2013"},{"volume-title":"Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications","year":"2001","author":"Gabrielsson","key":"B16"},{"key":"B17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10928-017-9563-8","article-title":"Delayed logistic indirect response models: realization of oscillating behavior","volume":"45","author":"Koch","year":"2018","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"B18","doi-asserted-by":"crossref","DOI":"10.1201\/b17203","volume-title":"Mixed Effects Models for the Population Approach: Models, Tasks, Methods and Tools","author":"Lavielle","year":"2014"},{"article-title":"inventors; University of Basel, Assignee. Method and Computer Program for Predicting Bilirubin Levels in Neonates Patent US11662354B2. (2023)","year":"","author":"Koch","key":"B19"},{"key":"B20","doi-asserted-by":"publisher","first-page":"c869","DOI":"10.1136\/bmj.c869","article-title":"CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Moher","year":"2010","journal-title":"Br Med J"},{"key":"B21","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2307\/2987937","article-title":"Measurement in medicine: the analysis of method comparison studies","volume":"32","author":"Altman","year":"1983","journal-title":"J R Stat Soc Ser D"},{"key":"B22","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1542\/peds.2014-1919","article-title":"Discrepancies between transcutaneous and serum bilirubin measurements","volume":"135","author":"Taylor","year":"2015","journal-title":"Pediatrics"},{"key":"B23","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/jp.2009.38","article-title":"Evaluation of transcutaneous bilirubinometry in preterm neonates","volume":"29","author":"Schmidt","year":"2009","journal-title":"J Perinatol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41390-024-03081-y","article-title":"Skin color influences transcutaneous bilirubin measurements: a systematic in vitro evaluation","author":"Dam-Vervloet","year":"2024","journal-title":"Pediatr Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41390-019-0471-z","article-title":"How skin anatomy influences transcutaneous bilirubin determinations: an in vitro evaluation","volume":"86","author":"van Erk","year":"2019","journal-title":"Pediatr Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1111\/j.1651-2227.2012.02797.x","article-title":"Comparison of the transcutaneous bilirubinometers BiliCheck and Minolta JM-103 in preterm neonates","volume":"101","author":"Ebbesen","year":"2012","journal-title":"Acta Paediatr"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1824-7288-39-46","article-title":"Bilicheck vs JM-103 in identifying neonates not at risk of hyperbilirubinaemia","volume":"39","author":"Romagnoli","year":"2013","journal-title":"Ital J Pediatr"},{"key":"B28","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/s41390-020-01118-6","article-title":"Inter-device reproducibility of transcutaneous bilirubin meters","volume":"89","author":"Dam-Vervloet","year":"2021","journal-title":"Pediatr Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s00431-010-1383-4","article-title":"Measurements of neonatal bilirubin and albumin concentrations: a need for improvement and quality control","volume":"170","author":"van Imhoff","year":"2011","journal-title":"Eur J Pediatr"},{"key":"B30","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1542\/peds.2011-2586","article-title":"Limitations and opportunities of transcutaneous bilirubin measurements","volume":"129","author":"Bosschaart","year":"2012","journal-title":"Pediatrics"}],"container-title":["Frontiers in Digital Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fdgth.2025.1497165\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T16:01:58Z","timestamp":1739894518000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fdgth.2025.1497165\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":30,"alternative-id":["10.3389\/fdgth.2025.1497165"],"URL":"https:\/\/doi.org\/10.3389\/fdgth.2025.1497165","relation":{},"ISSN":["2673-253X"],"issn-type":[{"type":"electronic","value":"2673-253X"}],"subject":[],"published":{"date-parts":[[2025,2,18]]},"article-number":"1497165"}}